Fiduxosin

CAS: 208993-54-8

Ref. 3D-IIA99354

Produktinformation

• Name: Fiduxosin
• Synonyme: 8-Phenyl-3-[4-[(3aR,9bR)-1,3a,4,9b-tetrahydro-9-methoxy[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl]butyl]pyrazino[2',3':4,5]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione, 8-Phenyl-3-[4-[(3aR,9bR)-1,3a,4,9b-tetrahydro-9-methoxy[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl]butyl]pyrazino[2′,3′:4,5]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione, Pyrazino[2′,3′:4,5]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione, 8-phenyl-3-[4-[(3aR,9bR)-1,3a,4,9b-tetrahydro-9-methoxy[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl]butyl]-, pyrazino[2',3':4,5]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione, 8-phenyl-3-[4-[(3aR,9bR)-1,3a,4,9b-tetrahydro-9-methoxy[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl]butyl]-

Beschreibung

Fiduxosin is a peptide that belongs to the class of ligands, which are small molecules that bind to and activate receptors. Fiduxosin binds to and activates the protein ion channels, which are responsible for maintaining the membrane potential of cells. It has been shown to inhibit the activity of phospholipase A2, an enzyme that is involved in inflammation. Fiduxosin also binds to and activates the protein receptor known as Ligand-gated ion channels (LGICs), which are associated with pain transmission. LGICs are activated by GABA, a neurotransmitter involved in regulating pain sensitivity. Fiduxosin may be used as a research tool to study how peptides interact with proteins or antibodies.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 555.6 g/mol
• Formel: C₃₀H₂₉N₅O₄S
• Reinheit: Min. 95%